炎癥免疫反應(yīng)軟調(diào)節(jié)——藥物研究新方向(英文)
本文選題:inflammatory + immune; 參考:《中國藥理學(xué)與毒理學(xué)雜志》2017年10期
【摘要】:Inflammation reaction and immune response are inseparable at the levels of system,tissue,cell and molecule.Inflammatory immune responses(IIR)is defined a moderate or abnormal system responses of inflammatory immune related cells in responding to the internal and external environment changes of body.Inflammatory immune related cells(traditionally,eg,macrophages,dendritic cells,T cells and B cells,etc,and non-traditionally,eg,glial cells,endothelial cells,epithelial cells,fibroblasts,synovial cells and liver cells,etc),and cytokines/receptor signal transduction involved in IIR.In current clinic drugs,such as inhibitors of COXs,inhibitors of TNF-alpha,IL-6,IL~(-1)7,BAFF etc,traditional immunosuppressive drugs(eg,methotrexate,leflunomide)and novel kinase inhibitor(eg,JAKs inhibitor),suppress enzyme activity,gene synthesis and transcription,cytokines and receptor signal,etc,respectively.These drugs restrain the excessive activation function of inflammatory immune related cells,but at the same time,also inhibit the physiological response of these cells to signaling molecules,which cause physiological function disorder of cells and tissues,increase the risks of serious adverse drug reaction including infection and cancer.Soft regulation of inflammatory immune responses(SRIIR),that is regulating the activity of key molecules or interaction between molecules in cells and resulting in making excessive activation function back to normal physiological levels,is a novel direction of discovery and development of new drugs for the treatment of IIR related diseases.
[Abstract]:Inflammation reaction and immune response are inseparable at the levels of system,tissue,cell and molecule.Inflammatory immune responses(IIR)is defined a moderate or abnormal system responses of inflammatory immune related cells in responding to the internal and external environment changes of body.Inflammatory immune related cells(traditionally,eg,macrophages,dendritic cells,T cells and B cells,etc,and non-traditionally,eg,glial cells,endothelial cells,epithelial cells,fibroblasts,synovial cells and liver cells,etc),and cytokines/receptor signal transduction involved in IIR.In current clinic drugs,such as inhibitors of COXs,inhibitors of TNF-alpha,IL-6,IL~(-1)7,BAFF etc,traditional immunosuppressive drugs(eg,methotrexate,leflunomide)and novel kinase inhibitor(eg,JAKs inhibitor),suppress enzyme activity,gene synthesis and transcription,cytokines and receptor signal,etc,respectively.These drugs restrain the excessive activation function of inflammatory immune related cells,but at the same time,also inhibit the physiological response of these cells to signaling molecules,which cause physiological function disorder of cells and tissues,increase the risks of serious adverse drug reaction including infection and cancer.Soft regulation of inflammatory immune responses(SRIIR),that is regulating the activity of key molecules or interaction between molecules in cells and resulting in making excessive activation function back to normal physiological levels,is a novel direction of discovery and development of new drugs for the treatment of IIR related diseases.
【作者單位】: Institute
【基金】:supported by National Natural Science Foundation of China(81330081 and 81673444)
【分類號】:R91
【相似文獻(xiàn)】
相關(guān)期刊論文 前7條
1 Esam Z.Dajani;PROSTAGLANDINS: PHARMACOGY, MECHANISM AND APPLICATIONS IN PEPTIC ULCER DISEASE[J];中國臨床藥理學(xué)雜志;1989年02期
2 徐叔云,丁長海,魏偉,李俊,許建明;影響炎癥免疫反應(yīng)的藥物研究及其思路[J];藥學(xué)進(jìn)展;1997年02期
3 XU JianRong;WANG Hao;CHEN HongZhuan;;Muscarinic acetylcholine receptor modulators derived from natural toxins and diverse interaction modes[J];Science China(Chemistry);2013年10期
4 ;Complexity and characteristic frequency studies in ECG signals of mice based on multiple scale factors[J];Science China(Life Sciences);2011年06期
5 Samy Emara;Tsutomu Masujima;Walaa Zarad;Maha Kamal;Ramzia EL-Bagary;;On-line coupling of derivatization with pre-concentration to determine trace levels of methotrexate[J];Journal of Pharmaceutical Analysis;2013年01期
6 ;Receptor binding characteristics and cytotoxicity of insulin-methotrexate[J];World Journal of Gastroenterology;2004年16期
7 Sami Akbulut;Hulya Elbe;Cengiz Eris;Zumrut Dogan;Gulten Toprak;Emrah Otan;Erman Erdemli;Yusuf Turkoz;;Cytoprotective effects of amifostine,ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats[J];World Journal of Gastroenterology;2014年29期
相關(guān)會議論文 前3條
1 Stirparo Joseph J;Fu Lijie;Hite Scd DABTMark;SchiavoneKristen;;DNA Microarrays:Emerging Uses in Toxicology and Drug Development[A];中國毒理學(xué)會第三屆全國學(xué)術(shù)會議論文(摘要)集[C];2001年
2 何繼亮;;Investigating genetic damage in workers occupationally exposed to methotrexate[A];中國毒理學(xué)會第四屆全國學(xué)術(shù)會議論文(摘要)集[C];2005年
3 ;Biophysical studies on the interaction between Methotrexate and human serum albumin[A];中國化學(xué)會成立80周年第十六屆全國化學(xué)熱力學(xué)和熱分析學(xué)術(shù)會議論文集[C];2012年
,本文編號:1926828
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/1926828.html